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Abstract
Body fluids contain proteins that perform functions specific to different types of body
fluids. Therefore, the detection of signature peptides for these proteins can potentially identify a
body fluid in a forensic investigation. This project aimed to validate a method to detect signature
peptides in body fluids commonly found in sexual assault cases by LC-MS/MS. Signature
peptides for semen and saliva fluids were combined with two signature peptides for vaginal
fluids. Samples created using two donors each for saliva, semen, and vaginal fluids were
extracted using a trypsin digest, with separation of the protein and DNA fractions. The LCMS/MS was utilized in MRM mode to analyze the protein fractions and DNA fractions were
quantified. In a sensitivity study, a minimum volume of 0.005 µL of semen and 0.01 µL vaginal
fluid could still be detected. A study of stains on different substrates showed variability
between protein and DNA recovery. Two and three-component mixtures were created to analyze
the interferences between the body fluids. The semen peptides were detected in all but one
mixture while saliva peptides were detected as only a major component in a mixture. The DNA
fractions for semen stains or swabs contained sufficient male DNA for further analysis. One of
the vaginal peptides was detected in all vaginal samples with good sensitivity, but the second
vaginal peptide was not detected. This assay needs to be optimized further.
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Introduction
Body fluids such as saliva, semen, and vaginal secretions are routinely found at crime
scenes in connection with sexual assaults or other violent crimes. Determining what body fluid is
present can be imperative to the case. The presence of semen, for example, can prove sexual
activity and the presence of saliva could confirm a victim’s description of an assault. The
appearance of body fluid can be very deceiving (Orphanou, 2015). Human body fluid
composition is very complex and forensic body fluid identification has many limitations. One of
the main issues with identifying body fluids is deciding what body fluid is present and how to
move forward.
Reliable body fluid identification helps with crime reconstruction and laboratories to
target the most probative samples for DNA typing. Current body fluid identification assays can
be tedious which has contributed to the fact that the backlog of sexual assault cases is increasing
in crime laboratories (Quinlan, 2021). There is a need for fast, sensitive, and reliable methods to
identify body fluids (McKiernan et al., 2021).
This research aimed to modify a method previously developed by Browne et al. (2020)
for determining signature peptides in semen, and saliva using LC-MS/MS by adding peptide
markers for vaginal secretions. This method incorporations a novel trypsin lysis procedure,
which has the advantage that it provides a DNA fraction for STR analysis and a protein fraction
to identify the body fluid(s). This method was tested for body fluid detection limits using a
dilution series, and interference from other fluids in controlled mixtures containing varying ratios
of semen, saliva, or vaginal secretions. Furthermore, different swabs and fabrics were studied to
see if the method can be compatible with different substrates.
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Literature Review
Body Fluids and their Compositions
Saliva, Semen, and vaginal secretions are body fluids of interest in forensic casework.
Body fluids may be found at a crime scene or submitted as evidence after a hospital examination
(e.g., sexual assault kit). Body fluids can be an important part of case reconstruction and can aid
in verifying witness statements. Therefore, it is important to understand the composition of
possible body fluids that can be encountered. Saliva has multiple functions including food
digestion and acting as a protective mechanism for oral tissues. The proteins within saliva can be
bacteria-killing and favor different environments (van Nieuw Amerongen et al., 2004). For
example, histatins are more prevalent in an ionic environment. Furthermore, the three salivary
glands (parotid, submandibular, and sublingual) introduce different proteins (van Nieuw
Amerongen et al., 2004).
Another common body fluid found in forensic cases is semen and it is produced by the
prostate gland and the seminal vesicles. The function of semen proteins is mainly for the
formation of semen and reproduction (Uniprot, 2022). Semenogelin, a protein in semen, is a
main component of semen coagulation and is formed in the seminal vesicle (de Lamirande,
2007). Another thing to consider is the protein composition after a vasectomy. For example, a
vasectomy can alter the cysteine-rich secretory protein-1 proteins seen in semen (Légaré et al.,
2013).
Finally, the vaginal canal comprises of mucosa, muscularis, and adventitia (The Human
Protein Atlas, n.d.) and the pH is very acidic to protect the reproductive tract. The proteins in the
vaginal canal that make up the function of the vaginal secretion carry semen up the vaginal tract
and destroy bacteria or any foreign substance. Since body fluids have proteins that perform
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specific functions, some of the proteins can be unique to that body fluid. The peptides that make
up those unique proteins, are also specific and can be identified using mass spectrometry (Yang
et al., 2013). Although, there are many other ways to analyze body fluids including presumptive
testing and other confirmatory testing.

Presumptive Testing for Body Fluids
Presumptive testing is a screening tool to detect for the possible presence of the targeted
substance. Presumptive tools can be used for body fluids like blood, semen, and saliva. A
presumptive test can give an indication of the body fluid present, but a confirmatory test should
confirm the presence using a more specific technique. Some presumptive tests for body fluids
that will be mentioned below are color changing tests (amylase, acid phosphate), alternate light
sources (Sperm Tracker), and antigen tests (prostate specific antigen).
Color Changing Tests
Acid phosphatase (AP) is a color test that turns violet in the presence of semen. AP is an
enzyme present in many areas of the body but at much higher concentrations in the prostate
gland. The color change occurs when 𝛼-Naphthyl phosphate is added to a seminal stain to
produce 𝛼-Naphthol in the presence of the enzyme AP. Diazo blue B dye is then added and if 𝛼Naphthol is produced, a violet color will appear (Laux, 2003). The color test that is most often
used to determine the presence of saliva is based on the enzyme amylase. Amylase is present at
high concentrations in saliva and the function of the enzyme is to digest starch (Hedman et al.,
2011). To test for the presence of saliva, potassium iodine can be added to the sample to produce
a purple/grey color. Or Benedict’s solution can be used, which comprises of copper sulfate, and
the blue solution will turn red in the presence of amylase (Cochran et al., 2008). An advantage to
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a color test is it can give the analyst an idea of how to move forward with the sample. It also aids
in case reconstruction. A disadvantage of color tests is that they aren’t specific. For example,
false positives and negatives can occur leading to possibly missing crucial evidence.
Alternate Light Sources
Alternate light sources can also be used to detect body fluid stains like semen. They
provide a nondestructive and easy technique to detect body fluids for collection. Sperm Tracker
is a spray that detects semen and acid phosphatase through a napththyl reaction. It provides a
luminescent signal when semen is present and has shown to only dim with a high dilution and in
the presence of feces (Borges et al., 2017). Compared to the mini-Crime Scope, the Sperm
Tracker is superior because it is less easily inhibited. Advantages of this technique aid with crime
reconstruction because the spray can provide an overall pattern. Also, it is very beneficial with
showing body fluids or stains that weren’t present to the human eye.
Antigen Tests
The final type of presumptive test that will be mentioned is an antigen test. The antigen
test looks for the specific antigens like prostate-specific antigen (PSA) or semenogelin to
presumptively identify the body fluid. PSA is an epithelial protein created in the prostate gland
(Laffan et al., 2011). SERATEC PSA and RSID-Semen are tests that detect PSA and
semenogelin. SERATEC PSA uses an immunoassay approach to detect PSA while RSID-Semen
utilizes a screening strip to detect semenogelin. SERATEC PSA was found to be more sensitive
than RSID-Semen by a factor of 10!" and RSID-Semen produced a false positive result when in
presence of Femodene, a female contraceptive (Laffan et al., 2011). Overall, presumptive tests
can be very helpful in initially testing for a body fluid but can also be problematic if the sample
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is degraded, or if in the presence of another body fluid that could possibly inhibit the result.
Unlike a presumptive test, a confirmatory test is able to identify a body fluid confidently.

Confirmatory Testing for Body Fluids
DNA Methylation
Confirmatory testing is utilized to confidently identify body fluids. Some examples of
confirmatory tests for body fluids are DNA methylation, RNA testing, and sperm search. DNA
methylation detects the cytosine and guanine dinucleotides which are separated by a phosphate
group (CpG) that are naturally methylated. Each type of tissue can be determined based on the
level of methylation since it varies according to the body fluid (Frumkin et al., 2011). DNA
methylation is capable of detecting a specific body fluid for aged samples and in mixtures.
Furthermore, this process is more stable because DNA is more stable than RNA, which is helpful
in forensic samples, since the sample may be subject to many environmental factors. (Choung et
al., 2021).
RNA Methods
Although RNA is less stable than DNA, the confirmatory methods involving RNA are
specific and reliable. RNA is an essential molecule with many varieties that have many functions
within the body. Messenger RNA (mRNA), circular RNA (circRNA), and microRNA (miRNA)
are just a few types that can be used to identify body fluids. There is also a future for next
generation sequencing to detect single nucleotide polymorphisms that are present in mRNA and
can potentially distinguish between different individuals in a mixed sample (Ingold et al., 2020).
mRNA is the molecule created from coding DNA regions that is responsible for protein
production (Lynch & Fleming, 2021). Gene expression differs between each tissue in the body
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which creates a unique composition of mRNA transcripts. Juusola & Ballantyne (2005) produced
an octuplex system by identifying specific markers for blood, saliva, semen, and vaginal
secretions and found that each body fluid could be identified in single or mixed stains. Albani &
Fleming (2018) also identified four specific mRNAs for blood, semen, and menstrual fluid and
all of the markers were found to be present for the specific body fluid.
CircRNA is produced through pre-mRNA back splicing. CircRNA markers have been
added in addition to mRNA markers to increase the specificity and sensitivity of the experiment
(Liu et al., 2020). How circRNA is expressed isn’t completely understood so the analysis is
dependent on the ratio between circRNA and linear RNA. CricRNA is not subject to degradation
and is stable throughout the analysis due to its circular nature (Lynch & Fleming, 2021).
Finally, miRNA is a regulating, noncoding RNA sequence. miRNA is more stable than
mRNA due to its short length, but it is not human specific. Since miRNA are connected to
mRNA due to mRNA regulation, it can also be specific to certain body fluids. Although, miRNA
is less explored since it is a recent interest for identifying body fluids (Lynch & Fleming, 2021).
Sperm Search
Sperm search is a method that can be used to specifically identify sperm in a sample by
using a microscope. Typically, a Christmas Tree Stain with two dyes is used to dye the
spermatozoa. The Nuclear Fast Red is a red dye that dyes the head of the spermatozoa and
epithelial cell nuclei a red/pink color. The other dye is picroindigocarmine which dyes the
epithelial cell plasma and spermatozoa tails green (Zeffer, 2014). This is completed in a two-step
process with first adding the Nuclear Fast Red dye onto the microscope slide with the sample and
waiting about 15 minutes. Then, distilled water is added to wash the sample before the
picroindigocarmine dye is added. After a couple of seconds, the picroindigocarmine is washed
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off with ethanol. Once the slide is dried, an analyst can view the slide and determine if
spermatozoa are present (Zeffer, 2014). This technique is relatively specific expect the Nuclear
Fast Red dye can also dye yeast cells a pink color.
Although all the above methods can work to identify body fluids, proteomics has shown
to be a promising and specific way to identify body fluids. Proteins within the body can be
specific to a body fluid or tissue due to their function. Browne et al. (2019); Danielson et al.
(2018); Legg et al. (2014) (2017), and many others have shown success with identifying body
fluids with proteins and their signature peptides.

Body Fluid Identification using Proteins
Proteomics is the study of the proteins within a tissue or body fluid and where the proteins
are produced (Merkley et al., 2019). As stated previously, proteomics can be used to identify
body fluids because proteins have specific functions. The function of a protein may be specific to
that body fluid, or it may just be more abundant in that body fluid (Hu et al., 2011). Proteins are
made up of peptides which are essentially the building blocks of proteins (Vitorino, 2018).
Peptides are short amino acid sequences that are connected by peptide bonds to create a long
amino acid sequence or a protein (Yang et al., 2013).
The use of proteomics in forensic science to identify body fluids can be highly advantageous
to a case, especially when paired with mass spectrometry (Merkley et al., 2019). Also, evaluating
multiple peptides (multiplex) in one confirmatory test creates a fast and efficient way to identify
body fluids (Yang et al., 2013). But there can be issues with the interpretation that can impede
the analysis. First, the analysis of peptides can be much more difficult on a mass spectrometer
(MS) than for other substances. Also, the masses of peptides are very similar to their isomers
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which can cause a misinterpretation (Merkley et al., 2019). It is recommended to use a more
specialized software to analyze the data in conjunction with human interpretation. For example,
Spectrum Mill MS Proteomics Workbench software suite can be used and set with modifications
(Legg et al., 2014).
Several instruments have been used to identify and analyze proteins with and without a
trypsin digest. Furthermore, peptides and proteins can be analyzed in different ways depending
on what information needs to be collected. There is an untargeted study and a targeted study. An
untargeted study is usually used when as many proteins or peptides as possible need be identified
in one sample. An untargeted study by Legg et al. (2014), identified hundreds of proteins in the
human body and over two hundred proteins were found in the body fluids studied by LCMS/MS. A targeted analysis can be completed on specific peptides or proteins and is commonly
performed with an instrument utilizing a triple quadrupole in multiple reaction monitoring
(MRM) mode (Merkley et al., 2019). Some main instruments used to identify body fluids from
proteins are high performance liquid chromatography (HPLC), LC-MS/MS, and the matrix
assisted laser desorption ionization-time of flight-mass spectrometer (MALDI-TOF) (Legg et al.,
2014; Yang et al., 2013).

Instrumentation for Protein-Based Body Fluid Identification
MALDI-TOF-MS
The matrix-assisted laser desorption ionization-time of flight-mass spectrometer
(MALDI-TOF-MS) has three components: the ionization source, the analyzer, and the detector
(Tuma, 2003). The sample is placed on a metal plate or a stainless-steel probe and then the laser
is directed onto the sample. The laser creates an ion plume from the matrix and the analyte which
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then goes into the mass analyzer, TOF (Skoog et al., 2007). The TOF separates the molecules
depending on how long the molecules take to go through the tube when accelerated with the
same energy. The molecules hit the detector and the time it took the molecule to pass will
determine its mass-to-charge ratio (m/z) (Tuma, 2003).
The MALDI-TOF bottom-up approach can detect peptide markers from a trypsin digest
(Kamanna et al., 2017). This type of instrumentation provides a high-resolution analysis with
low detection limits. This instrumentation has, for example, been shown to have a high
specificity for human blood (Kamanna et al., 2017). Another advantage to MALID-TOF-MS is
the protein coverage it can provide with targeted and untargeted proteins (Yang et al., 2013). A
disadvantage of using this instrument for detecting body fluid specific peptides/proteins is that
the masses between the peptides could be similar to each other (Yang et al., 2013).
Raman Spectroscopy
Raman spectroscopy is the difference in scattering upon radiation of molecules
depending on the chemical makeup. The sample can be gas, liquid, or solid and the laser source
irradiates the sample creating the scattered radiation (Skoog et al., 2007). The amount of
scattering can give information about the sample and its identification. Recently, there have been
developments made to increase the sensitivity and selectivity specifically for protein studies
(Kuhar et al., 2021). Raman spectroscopy can differentiate between non-human and human
blood as well as discriminate between other body fluids. Furthermore, Raman spectroscopy is
nondestructive and is even more robust in the presence of chemometric models that can interpret
the data (Muro et al., 2016). Another advantage is that Raman can identify the proteins because
the secondary structures are quite different from each other. A disadvantage to using Raman is
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that the spectra are complex with only subtle differences so that body fluids can’t be
distinguished without sophisticated chemometrics software (Muro et al., 2016).
Attenuated Total Reflection-Fourier Transform-Infrared Spectroscopy (ATR-FT-IR)
ATR-FT-IR examines the reflection that occurs when the sample is hit with a beam of
radiation (Skoog et al., 2007) A depth of penetration occurs when the sample is hit with the beam
of radiation, and it penetrates the surface of the sample. This is also called an evanescent wave.
The weakened energy then reaches the detector to create a spectrum (Hinton-Sheley, 2021).
ATR-FT-IR is nondestructive and requires minimal sample preparation, which can make
it a better choice than FT-IR. ATR-FT-IR has been shown to qualitatively identify multiple body
fluids: human blood, saliva, semen, and vaginal secretions. Each body fluid can be identified
based on its characteristic peaks on the generate spectrum (Orphanou, 2015). ATR-FT-IR
analysis, combined with partial least squares discriminate analysis (PLSDA), can determine a
phenotype from blood (Mistek et al., 2019). This analysis is possible because of the difference in
the lipids and proteins from person to person. The ATR-FT-IR showed a 92% accuracy in
classifying for sex and race (Mistek et al., 2019). The advantages to using ATR-FT-IR is that
there is not sample preparation, and it is nondestructive. A disadvantage to using ATR-FT-IR is
that currently mixtures have not been studied and each body fluid can only be identified on its
own (Orphanou, 2015). This may not be helpful in a forensic situation since most of the time, the
analyst does not know what body fluid they are analyzing.
LC-MS/MS
LC-MS/MS is a powerful instrument that is known for its sensitivity, ease of use, and
working well with non-volatile substances (Skoog et al., 2007). The first step in this instrument
is the separation by the LC. Once the sample is injected, a high-pressure pump pushes the mobile
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phase and the sample toward the guard column where any contaminants are trapped to protect
the analytical column (Skoog et al., 2007). The sample is then introduced into the analytical
column. Reversed phase is commonly used so that the nonpolar components in the samples will
bind to the nonpolar stationary phase on the column. A gradient mobile phase is when the mobile
phases composition changes throughout the run. The use of a gradient mobile phase will move
the molecules through the column at different rates, depending on their polarity. The molecules
will then move to the detector or the tandem mass spectrometer.
The sample is first evaporated and ionized to make the liquid sample suitable for the
mass analyzer. The most common type of ionization source is electrospray ionization (ESI). The
mass analyzer is comprised of a quadrupole. A quadrupole consists of four parallel rods that
alternate between AC and DC voltages (Skoog et al., 2007) to separate the ions based on their
m/z. The ions are introduced to the first mass analyzer, where the precursor ion is filtered. Then,
the precursor ion is further broken down by application of collision energy and interaction with
gas molecules in the collision cell (Skoog et al., 2007). Finally, specific product ions are filtered
in the second quadrupole mass analyzer. Multiple reaction monitoring (MRM) will allow the
user to select specific precursor and product ions whereas full scan mode will provide a full mass
spectrum of the analyte. LC-MS/MS has been able to identify unique proteins in both MRM and
full scan mode in conjunction with the Spectrum Mill MS Proteomics workbench software suite
(Legg et al., 2014, 2017). MRM mode is used when specific peptides are chosen for analysis
(target analysis). Browne et al. (2019) analyzed and chose specific peptides to analyze specific
body fluids in MRM mode. They chose to analyze specifically for saliva with the peptides
SMR3B-1&2 and semen with the peptides SEMG-1&2 in the sample. Full scan was utilized in
Legg et al. (2014) when the goal was to detect multiple peptides in semen, saliva, blood, vagina
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fluid, and menstrual blood (untargeted analysis). Both methods can be used to identify body
fluids, but they are very different approaches in the manner the MS is acquired and processed.
All the instrumentation mentioned above is extremely helpful when identifying body
fluids. Most of instruments can identify body fluids even in mixtures. Probative body fluid stains
then are subject to DNA testing, here one approach is to identify male DNA using a Y-screen
method. Some positive samples are processed with differential DNA extraction which will create
a separate semen DNA fraction for easier analysis.

Direct to DNA or Y-Screen Assays
A Y-Screen can be used to detect male DNA present in a sample. The assay uses sodium
hydroxide (NaOH) to lyse the epithelial and sperms cell to prepare for quantitative real time
polymerase chain reaction (qPCR) quantification (Luyando, 2018). Typically, this assay is used
after a body fluid stain was located and tested presumptively positive, omitting any confirmatory
body fluid testing. If the sample contains enough Y-DNA, then the next step is differential
analysis to separate the male fraction from the female fraction. Since it has been shown that
fabric samples could interfere with this assay, the approach is better suited for sexual assault kits
with vaginal or other orifice swabs (Thermo Fisher Scientific, 2015). The assay incorporates an
internal PCR control (IPC) to indicate if inhibition is occurring.
A Y-screen kit used by the New York Office of Chief Medical Examiner, uses a lysis
method without sodium dodecyl sulphate (SDS), mercaptoethanol, and dithiothreitol (DTT), all
of which can inhibit qPCR. This assay was found to be sensitive enough to detect male DNA
with a single sperm cell and worked successfully on soiled denim (Hickey & Mayall, 2019).
Loop-mediated isothermal amplification (LAMP) is another technique used for male DNA
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detection instead of PCR. Fluorescent primers are not needed which is more economical and
allows for the signal to be detected by the naked eye. The colorimetric results from using LAMP
show that this technique is comparable to the post-LAMP electrophoresis (Scott et al., 2019).
Utilizing the Y-screen can show if a mixture is present and if the Y-component can be
recovered with STR analysis. If the mixture ratio between the small-autosomal component and
the Y-component is less than 1:20, the male STR profile can be recovered. If the ratio is more
than 1:20, then a differential extraction needs to be completed to try to separate the male fraction
from the female fraction, an alternative is Y-chromosomal analysis (Prinz et al., 1997).

Differential Extraction
One limitation of the Y-screen approach is that sexual assault kit samples routinely
contain a combination of female and male cells. These mixed samples result in complex
genotyping results, where the Short Tandem Repeat (STR) profile from the male perpetrator may
be obscured by the victim’s STR type. These results are more difficult to interpret and may
results in fortuitous associations with a person of interest. Differential extraction is a procedure
where an analyst first lyses the epithelial cells and pellets the sperm cells, then after several wash
steps uses dithiothreitol (DTT) to lyse the sperm cells for DNA extraction (Butler, 2009) This
separates the male fraction and female fraction in a sample. This extraction is time consuming
since there are many wash cycles required (Clark et al., 2021). Also, some of the male fraction
can be lost or stay mixed with the female fraction of DNA, which could be detrimental in a
forensic case with a limited sample (Clark et al., 2021). Using the Y -screen approach, the
analyst can determine if the male to female DNA ration and then complete a differential
extraction if required.
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Protein and DNA Co-Extraction
The Y-screen approach yields a DNA fraction but no body fluid information. To obtain a
protein extract for body fluid testing and a DNA fraction could be tedious, time consuming, and
consume a large amount of sample. Here simultaneous methods could reduce extraction time and
to use less of the sample. Kranes et al. (2017) used a trypsin digestion extraction in conjunction
with a microcon MW100 filter to separate the two fractions. The function of trypsin is to cleave
proteins at Lys and Arg residues to separate the peptides with K or R at C-terminal (Burkhart et
al., 2012). Kranes et al. (2017) compared trypsin and proteinase K as lysis enzymes and found
trypsin to yield more DNA and proteins than proteinase K. A microcon MW100 filter doesn’t
allow product to go through the filter unless it is smaller than 100 kDa. Therefore, most peptides
can flow through the filter, while the larger DNA molecules are retained. Once the peptide
fractions are recovered, the filter is inverted to retrieve the DNA. Kranes et al. (2017) found that
the peptides were particle free and ready for analysis on the mass spectrometry.
Peters et al. (2020) compared three simultaneous extraction methods including the one
mentioned above. The Qiagen AllPrep DNA/RNA/Protein Mini Kit, the CFSRE method, and the
Kranes et al. method were compared to see which method provided the best peptide peak area
intensity by UPLC-MS/MS, DNA quantification values, overall quality of genetic profile,
consistency among preparation replicates, and speed/cost and of workflow. Overall, the Qiagen
AllPrep and CFSRE method were not as successful as the Kranes et al. (2017) method because
the Qiagen AllPrep showed allele dropout and didn’t meet the protein identification criteria. The
CFSRE method was better than the Qiagen AllPrep but it still did not show interpretable results
for some of the protein targets. Overall, Kranes et al., method was the most successful because it
met all the criteria set (Peters et al., 2020).
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Research Goals
The goals for this research are to validate the signature peptides, previously analyzed by
Browne et al. (2019), SEMG-1 &2 for semen and SMR3B-1&2 for saliva by utilizing MRM
mode on the LC-MS/MS. Also, to introduce signature peptides NGAL-1&2 to identify vaginal
fluids. We hypothesize that SEMG-1&2 and SMR3B-1&2 will remain robust and reliable in
identifying the semen and saliva, and that NGAL-1&2 will be able to identify vaginal fluids.
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Materials and Methods
Sample Collection and Preparation
Three vaginal swabs, and two donors each for vaginal secretions, semen, and saliva were
used for this research project. Vaginal swabs, liquid vaginal secretions, and semen samples were
purchased from Lee BioSolutions (Maryland Heights, MO). To avoid freeze thaw cycles and
preserve the integrity of the sample the two semen donor secretions of 1.0 mL and the two
vaginal donor secretions of 100 µL were further aliquoted into four 1.5-mL Eppendorf tubes.
Vaginal fluid 1 had to be diluted with nuclease-free water in order to pipette the vaginal
secretion. Saliva was collected from two male volunteers, under a previously approved CUNY
IRB (project #2017-0800). Each donor provided around 2 mL of oral fluid into a 50-mL Falcon
tube. Oral fluid was collected from the male volunteers but will be referred to saliva for the rest
of the study. The samples were aliquoted into four 1.5-mL Eppendorf tubes just as the semen and
vaginal secretions had been.
For the substrate effect study, 2 𝜇L of semen, saliva, and vaginal secretions were pipetted
onto polyester swabs, cotton swabs, and a clean polyester T-shirt swatch. Each substrate was
tested three times for each donor. For a sensitivity study, neat and serial dilutions of all six body
fluid samples were added directly to an Eppendorf tube at the following volumes: 1.0 µL, 0.5
µL, 0.25 µL, 0.1 µL, 0.05 µL, and 0.025 µL. A further dilution series was completed to reach the
detection limit for each peptide and donor at the following volumes: 0.01 µL, 0.005 µL, 0.0025
µL, 0.0001 µL, and 0.0005 µL. The saliva samples were spun down after the first dilution series.
The body fluids were also mixed at various ratios in combinations of either two or three body
fluids. Both vaginal secretions samples were used but for both semen and saliva, the respective
donor whose samples consistently had higher concentrations in the previous studies was used.
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Vaginal samples from Donors 1 and 2 were mixed at different ratios with saliva from
Donor 2 and semen from Donor 2 on a polyester t-shirt cutting. The volume ratios of vaginal
fluid to saliva or semen were 100:1, 50:1, 10:1, 5:1, 1:1, 1:5, 1:10, 1:50, 1:100. Then, all three of
the body fluids were mixed on a polyester t-shirt cutting to determine whether each of the body
fluids could still be detected in the presence of varying concentrations of the different body
fluids. Table 1 shows the ratios created for the mixtures, using 4μL as the highest volume and
ensuring all the body fluids were major components. This was prepared separately with vaginal
fluid from Donors 1 and 2 with both semen Donor 2 and saliva from Donor 2.

Table 1. Mixture of three body fluids
Vaginal Samples

Semen 2

Saliva 2

4 μL

1 μL

4 μL

4 μL

4 μL

1 μL

4 μL

1 μL

1 μL

1 μL

1 μL

1 μL

1 μL

4 μL

4 μL

1 μL

1 μL

4 μL

1 μL

4 μL

1 μL

Standard Preparation
Vaginal signature peptides were added to the previously established assay (Browne,
2020) to create a more complex multiplex that would provide additional information in a sexual
assault case. The vaginal signature peptides were chosen based on Legg et. al. (2018) and
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Universal Protein Resource (UniProt, 2022). The protein chosen to detect vaginal secretion was
neutrophil gelatinase-associated lipocalin (NGAL), and sequences for two signature peptides,
NGAL-pep 1 and NGAL-pep 2, were provided using Genescript (Piscataway, NJ). Based on
Browne’s research, the semenogelin (SEMG) protein with SEMG1-pep1 and SEMG-1-pep2 and
the saliva protein SMR3B and the peptides SMR3B-pep1 and SMR3B-pep2 (Browne, 2020)
were kept as peptide targets. Table 2 lists the amino acid sequence for all the target peptides.

Table 2. Body Fluid Specific Proteins and Signature Peptides
Body
Fluid
Semen

Saliva

Vaginal
Secretion

Protein
Semenogelin1

Submaxillary
gland
androgen
regulated
protein 3B
neutrophil
gelatinaseassociated
lipocalin

Peptide
Name
SEMG1pep1
SEMG2pep2
SMR3Bpep1
SMR3Bpep2

Sequence
QGGSQSSYVLQTEELVANK

Overall
Charge
-1

DIFSTQDELLVYNK

-2

GPYPPGPLAPPQPFGPGFVPPPPPPPYGPGR

+1

IPPPPPAPYGPGIFPPPPPQP

Neutral

NGL-pep1

SYPGLTSYLVR

-1

NGL-pep2

TFVPGCQPGEFTLGNIK

Neutral

The synthetic peptides NGAL-pep1 and NGAL-pep2 were dissolved in nuclease free
water and optimized on the Shimadzu LC-MS/MS 8050 (Columbia, MD) to determine the
quantifier and qualifier ions. A 1-μg/mL concentration was needed to optimize the peptide so a
serial dilution starting at 1,000 μg/mL was completed. The other peptides for semen and saliva
secretions were diluted as needed. All the synthetic peptides were mixed at a concentration of 50
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nmol/mL in nuclease-free water. A dilution series was created from 50 nmol/mL down to 0.005
nmol/mL.

Trypsin Digestion and Microcon Filtration
The buffer ammonium bicarbonate was prepared by adding 10mL of nuclease-free water
to 0.5g of pre-weighed ammonium bicarbonate. Each sample was placed in a 1.5 mL Eppendorf
tube and 98 𝜇L of the buffer, 1 𝜇L of 1% Protease Max (Promega, Madison, WI), and 1 𝜇L of
0.5M dithiothreitol (DTT) was added to the liquid or substrate sample. It was then incubated at
56° C while shaking at 1400 rpm for 20 minutes. Three microliters of indole acetic acid (IAA)
were added to each sample to conserve the disulfide bonds from separation. This was then placed
in the dark for 20 minutes at room temperature. To each sample, 1 𝜇L of DTT was added to
deactivate the IAA (Sigma Aldrich, St. Louis, MO) and then placed again in the dark for 20
minutes. One microliter of 0.1 𝜇g/μL solution of trypsin was added to each sample and then the
mixture was set to incubate for 3 hours at 37° C while shaking at 1400 rpm. The trypsin
(Promega, Madison, WI) was then deactivated by placing the samples in a heat block at 99° C
for 10 minutes. To extract the DNA and peptides from the substrate or swab, a dolphin tube with
a spin basket was used. The sample was placed in a spin basket inside the dolphin tube
(MIDScientific, Valley Park, MO) and the sample was spun down for 5 minutes at 1,500 rcf.
Negative controls were included in each extraction completed to ensure the reagents were not
contaminated.
A Microcon DNA Fast Flow (Millipore, Burlington, MA) filter unit was used for each
sample to separate the protein fractions from the DNA. The sample from the dolphin tube was
added to the Microcon filter unit and centrifuged for 20 minutes at 500 rcf. The flow through
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contained the protein fractions and it was transferred into a protein low bind tube. The protein
fractions were placed in the -80ºC freezer. The DNA fractions were recovered by inverting the
Microcon filter and placing it into a new Microcon tube and centrifuging for 3 minutes at 1,000
rcf. The DNA fractions were then placed in a new Eppendorf tube and stored in the 20ºC freezer.

DNA Quantification
Quantification with the Quantifiler Trio DNA Quantification Kit from ThermoFisher was
used to determine the human DNA concentration in the sample. Standards with predetermined
concentrations were prepared to create a standard curve. The DNA standard in the kit was first
diluted to a concentration of 50 ng/μL and a serial dilution was completed to 0.05 ng/μL
following the manufacturer’s instructions. The Quantifiler THP PCR Reaction Mix and the
Quantifiler Trio Primer Mix were used as a master mix. Per each sample, 5 μL of Primer Mix
and 4 μL of Reaction Mix were utilized. The reaction takes place in a 96-well plate, where 9 μL
of master mix and 2 μL of each sample were added to each well based on the corresponding well
on the plate map. The QuantStudio 5 (Thermo Fisher Scientific, Waltham, MA) was used for
quantification and the software to collect and analyze the data was HID Real-Time PCR
Software v1.3 (Thermo Fisher Scientific, Waltham, MA). Refer to Figure 1 below for the
thermal cycle process. The small autosomal and the Y-chromosome targets were interpreted.

95° C
95° C
60° C
→ 40 𝑐𝑦𝑐𝑙𝑒𝑠 𝑜𝑓 L
,
Q
2 𝑚𝑖𝑛𝑢𝑡𝑒𝑠
9 𝑠𝑒𝑐𝑜𝑛𝑑𝑠 30 𝑠𝑒𝑐𝑜𝑛𝑑𝑠
Figure 1. Thermal Cycling Conditions for Real-Time PCR System
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Peptide Analysis
The Trypsin digested peptide fractions obtained after the Microcon filtration step are suitable for
further analysis without additional treatment. The protein fractions were analyzed by a Liquid
Chromatograph Tandem Mass Spectrometer (LC-MS/MS), Shimadzu 8050-LCMS triple
quadrupole (Columbia, MD) with electrospray ionization in positive mode (ESI+) as the ion
source. Multiple reaction monitoring (MRM) was used in order to pick specific ionizations and
quantify the peptides. The injection volume was set to 20 𝜇L. The samples were placed straight
into LC-MS/MS vials and a calibration curve containing a mixture of all the synthetic peptides in
the buffer of ammonium bicarbonate was also analyzed. The column employed for this
experiment was the Agilent AdvanceBio Peptide mapping column (100 mm x 2.1 mm, 2.7 𝜇m).
The column conditions were as follows; the flow rate was 0.5 mL/min at 55° C for the column
temperature; the MS was nebulizing gas was at 2 L/min; heat and drying gas at 10 L/min
interface temperature 400° C; desolvation line (DL) temperature 250° C and a heat block
temperature of 400° C. Mobile phase A contained water and 0.1% formic acid and mobile phase
B contained acetonitrile and 0.1% formic acid. See Figure 2 below for the gradient scheme.
All of signature peptides were analyzed for each sample to ensure specificity between
body fluids. The instrument analyzed each retention time and ion ratio for the peptides, but each
sample was checked to ensure the correct parameters were set. The areas and concentrations
were provided for each sample, but the concentration (nmol/mL) represents how much of that
peptide is in the sample.
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0-20
minutes;
5-40% B

20-21
minutes;
40-95%
B

21-24
minutes;
95% B

24-25
minutes;
95-5% B

25-30
minutes;
5% B

Figure 2. Steps for Gradient Scheme on the LC-MS/MS

Statistical Methods
The average, standard deviation, and relative standard deviation (RSD) were calculated
from excel. The average was utilized to understand the triplicate replication on different
substrates. The standard deviation was calculated to understand the differences in substrates and
between donors. See Figure 3 for the equation used to calculate standard deviation. The RSD
was used in order understand the percent variability of the donor for the substrates studied. See
Figure 4 for the equation used to calculate RSD.

Σ(𝑥# − 𝜇)$
T
𝜎=
𝑁
Figure 3. Equation for Standard Deviation

𝑅𝑆𝐷 =

𝜎
𝑥 100
𝜇

Figure 4. Equation for Relative Standard Deviation
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Results
Peptide Results
Optimization and Calibration for Multiplex for LC-MS/MS
In the previous study by Browne (2020) SEMG and SMR3B were optimized, and their
precursor and product ions were determined. The precursor ion for SMR3B-1, a saliva signature
peptide, is 1034.8 m/z. The quantifier product ion is 614.9 m/z, and the qualifier product ion is
517.8 m/z. The precursor ion for SMR3B-2 is 711.0 m/z, the quantifier product ion is 628.4 m/z,
and the qualifier product ions are 614.4 m/z and 438.3 m/z. The precursor ion for SEMG 1, a
semen signature peptide, is 680.0 m/z. The quantifier product ion is 136.2 m/z, and the qualifier
product ion is 332.3 m/z. The precursor ion for SEMG-2 is 843.0 m/z, the quantifier product ion
is 201.2 m/z, and the qualifier product is 424.3 m/z.
After NGAL-1 and NGAL-2, the vaginal signature peptides, were added to the multiplex
a new optimization was required to determine the product and precursor ions for the additional
peptides was required. To determine the transitions of NGAL-1 and NGAL-2, a serial dilution
was performed from 1000 µg/mL to 1 µg/mL and run on the LC-MS/MS. NGAL-1 was found to
have a precursor ion of 628.2 m/z, a quantifier ion of 503.0 m/z, and the qualifier ions are 908
m/z and 223 m/z. The precursor ion for NGAL-2 is 603.3 m/z. The quantifier ion is 221 m/z, and
the qualifier ions are 229 m/z and 120 m/z. See Table 3 for the full report of the transitions for
each peptide and their retention time.
To determine the cut off for each signature peptide, the following dilution were made for
each peptide: 0.1 nmol/mL, 0.05 nmol/mL, 0.025 nmol/mL, 0.01 nmol/mL, 0.005 nmol/mL, and
0.0025 nmol/mL. See Table 4 below for the cut-offs for each peptide. Figure 5 represents a
MRM chromatogram of the multiplex of the synthetic peptides.
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Table 3. LC-MS/MS transitions for synthetic peptides
Peptide Name

Precursor m/z

Product m/z

Retention Time (min)

SMR3B-1

1034.8

14.2

SMR3B-2

711.0

SEMG-1

680.0

SEMG-2

843.0

NGAL-1

628.2

NGAL-2

603.3

614.9*
517.8
628.4*
614.4
438.3
136.2*
332.3
201.2*
424.3
503*
908
223
221*
229

13.0

10.3
12.2
10.9

12.3

120
*Quantifier Ions

NGAL-1

1:SMR3B-pep1 TIC (+)
2:SMR3B-pep2 TIC (+)
3:SEMG1-pep1 TIC (+)
4:SEMG1-pep2 TIC (+)
20000000 5:NGL-1 TIC (+)
6:NGL-2 TIC (+)

17500000

12500000

2500000

NGAL-2

5000000

SMR3B-1

7500000

SMR3B-2

SEMG-2

10000000

SEMG-1

Abundance

15000000

0
7.0

7.5

8.0

8.5

9.0

9.5

10.0

10.5

11.0

11.5

12.0

12.5

13.0

13.5

14.0

14.5

Retention Time (min)

Figure 5. Chromatogram Showing the Multiplex with Synthetic Peptides
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15.5
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16.5

17.0
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Table 4. Cut-Offs for each Synthetic Peptide in the Multiplex
Peptide

Cut-Off (nmol/mL)

NGAL-1

0.005

NGAL-2

0.05

SMR3B-1

0.05

SMR3B-2

0.005

SEMG-1

0.005

SEMG-2

0.0025

Substrate Study in Triplicate
All body fluids were tested in triplicate on cotton swabs, polyester swabs, and cuttings of
a polyester t-shirt. All substrates were tested alone as a negative control, and no peptides or DNA
were detected. Two microliters of each body fluid were pipetted onto each substrate. For the
vaginal fluids, the substrate with the highest concentration for NGAL-1 was the cotton swab,
then the polyester T-shirt cutting, and finally the polyester swab. Figure 6 shows a visual
representation of the substrates with both vaginal fluids. Vaginal Fluid 1 & 2 yielded around the
same concentration for each substrate. NGAL-2 was not detected for both donors on any of the
substrates. This issue occurred throughout the entirety of the study.
Semen from both donors 1 & 2 was placed on each substrate. Figure 7 represents the
concentration of SEMG-1 and SEMG-2 on each substrate. SEMG-1 had the highest
concentration extracted from the polyester swab and the lowest concentration from the cotton
swab. SEMG-2 showed this same pattern as SEMG-1. Donor 1 had an overall higher
concentration of SEMG-1 and SEMG-2.
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Finally, SMR3B-1 had a higher concentration with the cotton swab. The polyester swab
then yielded a higher concentration than the polyester t-shirt. For SMR3B-2, the polyester swab
showed the highest concentration, and then the cotton swab. Between the peptides, SMR3B-2
consistently had a higher concentration overall compared to SMR3B-1. Figure 8 demonstrates
the difference between the two peptides.
The relative standard deviation was calculated to show the variability between the
substrates. Figure 9 shows that the polyester t-shirt cuttings produce the highest variability
between the peptides. SMR3B-1 and SMR3-2 have the lowest RSD values, under 40%. NGAL-1
consistently has the highest RSD, around 70%. The large RSD values could be due to only
having two donors for each body fluid. A larger sample size would give a more accurate
representation of variability between the substrates.

Concetration of Peptide (nmol/mL)

0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

0.585

0.430

0.434

Cotton Swab

Polyester Swab

Polyester T-Shirt

NGAL-1

Figure 6. Vaginal fluid on all three substrates. Shown are the average vaginal peptide
concentration for both donors and triplicate stains. N=6 for each substrate.
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Concentration of Peptide (nmol/mL)

25
20
15
10
5
0

14.725

6.077

Cotton Swab

20.689

17.439

Polyester Swab
SEMG-1

17.228

13.365

Polyester T-Shirt

SEMG-2

Figure 7. Semen on all three substrates. Shown are the average semen peptide concentrations for
both donors and triplicate stains. N=6 for each substrate.

Concentration of Peptide (nmol/mL)

3.5
3
2.5
2
1.5
1
0.5
0

0.977

2.577

Cotton Swab

0.834

2.731

Polyester Swab
SRM3B-1

0.628

1.532

Polyester T-Shirt

SMR3B-2

Figure 8. Saliva on all three substrates. Shown are the average saliva peptide concentrations for
both donors and triplicate stains. N=6 for each substrate.
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80
70
60

RSD %

50
40
30
20
10
0
Cotton Swab
SMR3B-1

Polyester Swab
SMR3B-2

SEMG-1

SEMG-2

Polyester T-Shirt
NGAL-1

Figure 9. Relative Standard Deviation for each substrate. Shown is the percentage variability of
the three substrates for each peptide across two donors and triplicate stains.

Table 5. Average peptide concentrations for both donors on different substrates
Peptide

Donor

Cotton Swab

Polyester Swab

Polyester T-Shirt

SMR3B-1

1

1.604

0.857

0.43

2

0.889

0.811

0.825

1

2.524

2.677

0.891

2

2.630

2.786

2.173

1

9.253

11.31

7.170

2

20.19

30.07

27.29

1

3.178

9.155

5.712

2

8.976

25.72

21.02

1

0.951

0.701

0.715

2

0.219

0.159

0.153

SMR3B-2

SEMG-1

SEMG-2

NGAL-1
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Table 5 shows averages over the triplicates for all donor substrate combinations. The body fluid
specific peptides displayed different concentrations, with SEMG-1 and -2 having the strongest
signal and NGAL-1 the lowest. These differences reflect the different concentrations of the target
protein in the respective body fluid and were consistent throughout the rest of the study.

Sensitivity Study
To determine the minimum volume for each peptide to be detected, a sensitivity study
was conducted. Each body fluid was first diluted to represent volumes from 1.0 µL to 0.025 µL.
All the peptides besides SMR3B-1 reached the detection limit at 0.25 µL. Another dilution series
was created to cover lower volumes from 0.01 µL to 0.0005 µL. It was determined that the cutoff for SMR3B-1 was 0.5 µL and SMR3B-2 was 0.025 µL. Both SEMG-1 and SEMG-2 had a
detection limit of 0.005 µL. The cut-off for NGAL-1 was 0.01 µL.
SMR3B-2 was still detected at 0.025 µL but was not detected in the second dilution
series. The saliva from both donors was centrifuged between these two studies because it was
challenging to pipette. A considerable quantity of peptides could have been left in the mucous
pellet created and discarded by centrifuging the saliva. Therefore, it is likely that the detection
limit for SMR3B-2 is lower than 0.25 µL.
Figures 10 and 11 represents the dilution series for both semen peptides. Semen Donor 1
consistently had a higher concentration than Donor 2 for SEMG-1 and SEMG-2. Figure 12
represents NGAL, and it is evident that vaginal fluid 1 has a higher concentration than vaginal
fluid 2, where no decrease was observed. The vaginal fluid from Donor 1 was diluted in a 1:1
ratio initially with nuclease-free water because it was a paste-like consistency. The dilution series
for vaginal fluid 1 may have been more successful because it was easier to pipette. Finally, a
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dramatic decline in concentration occurred for SMR3B-2 after 1 µL (see Figure 13) but the
peptide was still detected at 0.025 µL.

Concentration of Peptide (nmol/mL)

70
60
50
40
30
20
10
0
1

0.5

0.25

0.1A

Semen Donor 1

0.1B

0.05

0.025

0.01

Semen Donor 2

Figure 10. Semen dilution series. Shown are SEMG-1 concentrations for both semen samples.

Concentration of Peptide (nmol/mL)

35
30
25
20
15
10
5
0
1

0.5

0.25

0.1A
Semen Donor 1

0.1B

0.05

0.025

0.01

0.005

Semen Donor 2

Figure 11. Semen dilution series. Shown are SEMG-2 concentrations for both semen samples.
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Concentration of Peptide (nmol/mL)

0.6
0.5
0.4
0.3
0.2
0.1
0
1

0.5

0.25

0.1A

Vaginal Fluid 1

0.1B

0.05

0.025

0.01

Vaginal Fluid 2

Figure 12. Vaginal fluid dilution series. Shown are NGAL-1 concentrations for both vaginal
donors.

Concentration of Peptide (nmol/mL)

3
2.5
2
1.5
1
0.5
0
1

0.5

0.25
Saliva Donor 1

0.1A

0.1B

0.05

0.025

Saliva Donor 2

Figure 13. Saliva dilution series. Shown are SMR3B-2 concentrations for both saliva donors.

Mixtures
Body fluids were placed on polyester t-shirt at the following ratios of vaginal to semen
and saliva fluids, 100:1, 50:1, 10:1, 5:1, 1:1, 1:5, 1:10, 1:50, and 1:100. The mixture series was
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repeated for both vaginal fluid samples but using the same semen and saliva donor (donor 2 in
each case). See Table 6 for the results of two-component mixtures. NGAL-1 is present in all
ratios, and a consistent pattern is followed. SEMG-1 and SEMG-2 do not appear when present as
a minor component in the 100:1 ratio. SMR3B-1 was only detected as a major component from
1:10 to 1:100. SMR3B-2 was not detected as a minor component. It was detected at 5:1 but not at
the 1:1 ratio. Although, SMR3B-2 was detected as the major component from 1:5 to the 1:100
ratio.

Table 6. Signature peptide detection in two-component mixtures
Ratio (Vaginal fluid: NGAL-1
Semen/Saliva)
(nmol/mL)
100:1
0.5145

SEMG-1
(nmol/mL)

SEMG-2
(nmol/mL)

SMR3B-1
(nmol/mL)

SMR3B-2
(nmol/mL)

50:1

0.473

0.17

0.067

10:1

0.3295

0.777

0.489

5:1

0.1935

0.978

0.615

1:1

0.0635

1.721

0.602

1:5

0.075

6.881

2.268

1:10

0.0775

9.877

3.811

0.503

0.845

1:50

0.063

30.309

12.943

0.849

2.495

1:100

0.067

42.342

20.314

1.59

5.077

0.441

0.52

*The values for NGAL-1 are averaged from all four samples mixed with semen and saliva*

A three-component mixture series was included to test for any further interferences
occurred with a more complicated mixture. See Table 11 in the Materials and Methods to see the
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ratios created for this mixture series. Only 1:10 dilutions of each body fluid were used to create
the ratios for the three-component mixture. Table 7 contains the concentrations in nmol/mL for
each peptide in the mixture with vaginal fluid donor 1.

Table 7. Signature peptide detection in three-component mixtures
Vaginal:
Semen:
Saliva
4:1:4 (C1)

NGAL
0.12

SEMG-1
1.171

SEMG-2
0.901

4:4:1 (C2)

0.104

5.895

2.932

4:1:1 (C3)

0.126

1.063

0.791

1:1:1 (C4)

0.062

1.545

0.77

1:4:4 (C5)

0.054

6.321

3.109

0.24

1:1:4 (C6)

0.066

1.3

0.749

0.258

1:4:1 (C7)

0.053

5.856

2.311

SMR3B-1

SMR3B-2
0.304

For this mixture series, NGAL-1 was detected in all the ratios despite being a minor
component. The values for NGAL-1 are consistent with the volume in the mixture. When
NGAL-1 is the major component (0.4 µL), the average concentration is 0.117 nmol/mL. When
NGAL-1 is the minor component (0.1 µL), the average concentration is 0.059 nmol/mL. SEMG1 and SEMG-2 are both present in the mixture as major and minor components. The
concentration for SEMG-1 is higher than SEMG-2 for all the mixtures. For SEMG-1, the average
concentration as the major component is 6.024 nmol/mL. As the minor component, the average
concentration of SEMG-1 is 1.270 nmol/mL. SEMG-2 has an average of 2.784 nmol/mL as the
major component and 0.803 nmol/mL as the minor component. SMR3B-1 was not present in the
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mixtures, and SMR3B-2 was only present as a major component. The average concentration for
SMR3B-2 as the major component was 0.267 nmol/mL. Despite the differences in concentration
between the body fluids, the ones detected were above the cut-off.

Mock Cases
Three 5-year-old vaginal swabs were collected from the -20° C freezer and tested in
combination with semen Donor 1 and saliva Donor 1. Each swab was cut into three sections. One
µL of fluid from Semen Donor 1 was added to 1/3 of each swab in an Eppendorf tube, and one
µL of fluid from Saliva Donor 1 was added to the other 1/3 of each swab in an Eppendorf tube.
The last third of the swab was used as a negative control to ensure no other body fluids were
detected besides the vaginal fluid.
All peptides were detected besides NGAL-2. SMR3B-1 was detected at an average of
5.277 nmol/mL, and SMR3B-1 was detected at an average of 4.362 nmol/mL. SEMG-1 and
SEMG-2 were detected at an average of 10.289 nmol/mL and 0.574 nmol/mL. NGAL-1 was
detected in all swabs for an average of 0.382 nmol/mL. Figure 14 shows the multiplex of a mock
case containing vaginal and saliva fluids and Figure 15 shows the multiplex with vaginal and
semen fluids. Analyzing the mock cases was a successful experiment, and all the body fluids
were detected.
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NGAL-1

1:SMR3B-pep1 1034.8000>614.8500(+) CE: -24.0
75000 1:SMR3B-pep1 1034.8000>517.8000(+) CE: -39.0
2:SMR3B-pep2 711.0000>628.4000(+) CE: -17.0
2:SMR3B-pep2 711.0000>614.3500(+) CE: -20.0
70000 2:SMR3B-pep2 711.0000>438.3000(+) CE: -32.0
5:NGL-1 628.3000>503.4000(+) CE: -19.0
65000 5:NGL-1 628.3000>223.1500(+) CE: -30.0
5:NGL-1 628.3000>908.5000(+) CE: -24.0
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Figure 14. A chromatogram of the multiplex with a mock case of vaginal and saliva fluids
-47.0
-18.0
-47.0
-24.0

NGAL-1

3:SEMG1-pep1 680.0000>136.2500(+) CE:
3:SEMG1-pep1 680.0000>332.2000(+) CE:
4:SEMG1-pep2 843.0000>201.2000(+) CE:
4:SEMG1-pep2 843.0000>424.2500(+) CE:
5:NGL-1 628.3000>503.4000(+) CE: -19.0
110000 5:NGL-1 628.3000>223.1500(+) CE: -30.0
5:NGL-1 628.3000>908.5000(+) CE: -24.0
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Figure 15. A chromatogram of the multiplex with a mock case of vaginal and semen fluids
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DNA Results
The DNA fractions were extracted simultaneously with the peptide fractions. The DNA
fractions were quantified, but no further analysis was completed due to time restraints. Although,
completing the quantification step gave important insight into the possibility of downstream
analysis.

Substrate Study
The substrate study again showed an effect of the substrate on DNA recovery. Table 8
shows that the two donors for each body fluid differ in their average DNA concentrations. This is
caused by biological variation in cell counts in each body fluid. For all three body fluids, the
polyester swab yielded the lowest DNA concentrations.

Table 8. Average DNA concentrations (ng/µL) for triplicate stains on different substrates

Saliva

Semen

Vaginal Fluid

Cotton Swab
1
0.30

Polyester
Swab

Polyester TShirt
0.22

0.40

2

2.05

0.85

2.88

1

1.90

0.25

3.01

2

7.05

2.50

5.96

1

4.86

0.51

4.98

2

0.41

0.11

1.91

This substrate effect differed from the peptide results. Polyester swabs had the highest
concentration for the semen peptides, SEMG-1 and 2. For saliva, the two peptides differed in
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which substrate had the highest signal, but results were very similar for both swab types. Also,
the vaginal fluids and NGAL-1 peptide concentration was similar between the polyester swab
and the polyester t-shirt. See Table 9 to see the differences between the DNA fractions and the
peptide fractions both vaginal fluids.

Table 9. Average peptide and DNA concentrations for both vaginal fluids

Vaginal Fluids
Polyester Swab
Polyester T-Shirt
Cotton Swab

DNA
Peptide
(ng/µL)
(nmol/mL)
0.31
0.4296
3.4

0.4341

2.61

0.5851

Sensitivity Study
The quantification of the sensitivity study showed a lower limit of DNA for vaginal fluids
and semen fluids. DNA from vaginal Fluid 1 was still detected at 0.001 µL (See Figure 16), and
the same was true for semen Donor 1, where this amount of semen showed a DNA concentration
of 0.0002 ng/µL. Please note that these concentrations are not sufficient for a DNA profile.
Based on, for example, the Globalfiler STR amplification kit validation, 60pg or 0.004 ng/µL of
single source DNA are required for complete to almost complete genotypes (Ludeman et al.,
2018). This concentration was obtained for 0.0025 µL of vaginal fluid and 0.01 µL of semen. For
saliva the first set of dilution down to 0.025 µL yielded detectable DNA, but as with peptide,
further dilutions were negative. These more diluted samples were created after the saliva was
centrifuged. This may have pelleted buccal epithelial cells caused the loss of some of the DNA.
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0

Vaginal Donor 2

Figure 16. Vaginal dilution series. DNA concentrations of vaginal fluid samples 1 and 2.

Mixture Study
The vaginal fluid with saliva or semen mixtures were evaluated for the presence of male
DNA to determine which samples would have yielded a male DNA profile. The male target in
the current forensic human quantification kits is the key to the Y-screen casework concept. The
male target will detect male DNA in a mixture and together with the autosomal targets provides
information on how to proceed with a DNA sample. In the two-component mixture with the
vaginal component and the semen or saliva, the Quantifier Trio still detected male DNA at the
100:1 vaginal: semen or saliva ratio. At the 100:1 for semen, the concentration for the Y-target
was 0.01 ng/µL, which would be sufficient for a full Y-STR DNA profile. For saliva, the
concentration was 0.0037 ng/µL, this amount may or may not yield a useable profile (Ludeman
et al., 2018) See Figure 17 and Figure 18 for the concentration of semen and saliva at each
mixture ratio.

39

Concentration of DNA (ng/µL)
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Figure 17. Two component mixture with semen. Shown is the male DNA of both semen samples
at the different mixture ratios with vaginal fluid.

Concentration of DNA (ng/µL)
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100:1
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5:1
Saliva Donor 1
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1:5

1:10

1:50

1:100

Saliva Donor 2

Figure 18. Two component mixture with saliva. Shown is the male DNA of the saliva samples at
the different mixture ratios with vaginal fluid.

All the three-component mixtures yielded enough small-autosomal DNA for future DNA
typing. The lowest amount of DNA detected was 0.08 ng/µL, and the highest amount was 2.46
ng/µL. More importantly, each mixture also yielded enough male DNA. When saliva is the
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major component, the average Y-DNA concentration was 0.078 ng/µL. The average amount of
Y-DNA detected when semen was the major component was 0.463 ng/µL. When both semen
and saliva are the major components, the average Y DNA detected is 0.35 ng/µL. When saliva
and/or semen were the minor components, an average of 0.123 ng/µL was detected as male
DNA. In Figure 19, C2, C5, and C7 represent the highest concentration of Y-DNA. This is
because semen is a major component in C2 and C7 and both semen and saliva are major
components in C5.

Concentration of DNA (ng/µL)

1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
C1

C2

C3

C4

Small Autosomal

C5

C6

C7

Y

Figure 19. Three-component mixture of vaginal fluid, semen, and saliva. Shown is the
comparison of the concentrations of small autosomal DNA to Y-DNA.

Mock Cases
The quantification on the mock cases determined that the amount of male DNA detected
on all three swabs was sufficient for DNA typing, but the ratio between the total human DNA
(small autosomal target) and the Y-chromosome target showed that only the semen samples had
mixture ratios suitable for regular STR typing (see Table 10). The minor component is only
detectable if the ratio is less than 1:20, for more extreme female to male DNA mixture only Y-
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STR typing will reveal the male DNA genotype (Butler, 2009). Vaginal Swab 1 yielded the most
DNA with both semen and saliva. On average, the vaginal swabs with the saliva contain 0.045
ng/µL of male DNA; the SA:Y ratios showed 600-1300x excess of autosomal DNA. The vaginal
swabs with semen contained an average of 2.93 ng/µL of male DNA with a much smaller excess
of autosomal DNA.
Table 10. DNA concentrations for mock casework samples
Vaginal Swab
(VS) with Semen
or Saliva
VS1 Saliva 1

Small auto

Y target
104.36

SA:Y ratio
0.08
1304.50

VS1 Semen 1

72.82

6.18

11.78

VS2 Saliva 1

2.84

0.0044

645.45

VS2 Semen 1

3.89

1.08

3.60

VS3 Saliva 1

64.73

0.05

1294.60

VS3 Semen 1

19.55

1.54

12.69
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Discussion
This research aimed to further validate the semi-quantitative analysis of the semen
(SEMG-1 and SEMG-2) and saliva (SMR3B-1 and SMR3B-2) signature peptides that were
previously determined by Browne et al. (2019). The assay was modified by adding a vaginal
marker, the protein NGAL, to identify vaginal fluids. NGAL-1 and NGAL-2 were selected to the
assay due to the success in identifying vaginal fluids in other studies. Legg et al. (2017) verified
NGAL as an appropriate vaginal marker for identifying solely vaginal fluids. NGAL was present
in 100% of vaginal fluid samples and only in 6% of menstrual blood samples (Legg et al., 2017).
Furthermore, NGAL was only present in human samples, and no non-human origins were found
(Danielson et al., 2018). NGAL was also present in mixtures with saliva and semen, proving to
be an abundant and reliable biomarker for vaginal fluid (Danielson et al., 2018).
NGAL-1 was successful in this study, but NGAL-2 was not detected in any of the
conducted experiments. Danielson et al. (2018) and Legg et al. (2017) shared the same sequence
for one of the NGAL peptides, SYPGLTSYLVR. For the other peptide, Legg et al. (2017) used
TFVPGCQPGEFTLGNIK, and Danielson et al. (2018) used WYVVGLAGNAILR. Specific
detection of TFVPGCQPGEFTLGNIK was never mentioned in the Legg et al. (2017) study. In
this study, the peptide sequences used were SYPGLTSYLVR (NGAL-1) and
TFVPGCQPGEFTLGNIK (NGAL-2). Throughout this study, SYPGLTSYLVR (NGAL-1)
consistently was observed for each donor, and this specific peptide was reliable in detecting
vaginal fluids. TFVPGCQPGEFTLGNIK (NGAL-2) was not detected in any of the experiments.
The signature peptides for semen fluid, SEMG-1, and SEMG-2, were found to be
reliable, and abundant in all the studies. In this study, SEMG-1 and SEMG-2 had a minimum
volume detection of 0.005 µL. SEMG-1 and SEMG-2 were found in all the mixtures but the
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100:1 (vaginal: semen). Browne et al. (2019) found SEMG-1 and SEMG-2 to be detected at all
volumes (0.1 µL minimum). Also, they found SEMG-1 and SEMG-2 to be present in all
mixtures with saliva (Browne et al., 2019). Legg et al. (2017) detected SEMG-1 and SEMG-2 in
all mixtures with different body fluids like menstrual blood, urine, vaginal fluid, and saliva. With
the support from the previous studies and the findings in this study, one can state that SEMG-1
and SEMG-2 are abundant, robust, and can identify semen in a sample.
Looking at the saliva peptides, SMR3B overall was a reliable protein to use to identify
saliva. SMR3B-2 was found to be more abundant overall and was detected at a lower volume
than SMR3B-1. SMR3B-1 was detected until 0.5 µL while SMR3B-2 had a minimum detection
volume of 0.025 µL. Also, SMR3B-2 was only detected in the three-component mixture and
only when it was a major component while SMR3B-1 completely dropped out and no signal was
detected. Furthermore, Legg et al. (2017) also determined SMR3B to be a reliable protein for the
determination of saliva because it was found in 100% donors. SMR3B was detected in mixtures
with saliva and vaginal fluids, making the peptide specific for casework. Danielson et al. (2018)
also found that SMR3B-1 and SMR3B-2 can be detected with the required minimum transitions
at a 1:32 dilution. Browne et al. (2019) determined SMR3B-1 and SMR3B-2 to be found in all
donors and that SMR3B could be used to identify saliva. Although, it was not detected at 0.5 µL
or 0.1 µL in the sensitivity study. Overall, SMR3B can identify saliva as a body fluid in most
scenarios but only as a major component in a mixture.
The sensitivity studies determined the minimum volume at which each body fluid could
be detected. Detection of SEMG-1, and SEMG-2 was successful and showed a continuous
decline throughout each dilution series. Although, with semen Donor 1 and 2, the concentrations
of DNA did not decrease. Also, the dilution series for saliva Donor 1 also did not show a
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continuous decrease of DNA. The reason for this could be due to clumping or that the sample
was not evenly distributed prior to the dilution step. This was also found regarding the peptide
results in saliva. SMR3B-2 declined significantly after the first dilution. The dilutions were made
with nuclease-free water, and it is possible that the saliva was not evenly distributed in the water
due to the mucous and viscous nature of this body fluids. It was challenging to pipette from the
first dilution to the next due to amount of mucous in the sample and the correct amount may have
not been pipetted from the first to the second dilution. SMR3B-1 was not detected after 0.5 µL
and Browne et al. (2019) had similar findings with SMR3B-1. They found that SMR3B-1 was
not detected after 1µL.
After the first dilution series, NGAL-1, SEMG-1, SEMG-2, and SMR3B-2 were still
detected at 0.025 µL and more dilutions had to be made to reach the detection limit for each
peptide. Before this, both saliva samples were centrifuged to remove the mucous component, so
it was easier to pipette. Saliva Donor 1 and Donor 2 had a concentration of 0.392 and 0.412
nmol/mL at 0.025 µL for SMR3B-2, so it was projected that this peptide would at least be
detected at 0.01 µL. But no saliva peptides were detected in the second dilution series. The DNA
results were also negative, and the Y-target did not detect any male DNA. This indicates that the
centrifugations step removed all DNA containing buccal epithelial cells. The minimum volume
determined for the saliva peptides needs to be reinvestigated, and new samples should be tested
to determine if there is a lower limit of detection.
Different substrates were studied to ensure that this assay can work on similar substrates
that may be involved in a sexual assault case. Cotton swabs were chosen because they are
typically used for sample collection in sexual assault cases. Some sexual assault kits may also
contain polyester swabs and finally, the polyester T-shirt fabric was chosen because it is similar
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to the composition of some women’s underwear. This study was successful in detecting both
peptide and DNA fractions for all donors. Browne et al. (2019) also studied these substrates and
both peptide and DNA fractions were successfully detected.
For this substrate study, the results varied between peptides and DNA. SEMG-1 and
SEMG-2 showed the highest concentration with the polyester swab and NGAL-1, SMR3B-1 and
SMR3B-2 had the highest concentration with cotton swabs. The DNA results for all three body
fluids had the highest concentration on the polyester t-shirt cutting. The reason for this difference
may be due to the structure of the substrate. Bruijns et al. (2018) studied the DNA recovery of
cotton, polyester, rayon, foam, and nylon swabs. The authors mentioned that 20-76% of the
DNA can be lost during the extraction step. The authors also found that the swabs that were more
coiled, trapped the DNA containing cells in the swab and most of the DNA was unable to be
extracted (Bruijns et al., 2018). In this study, it was found that DNA was better recovered from
cotton swabs than the polyester swabs. The polyester swab may be more tightly coiled and
therefore trapping the DNA in the swab. The thin polyester fabric easily released cellular DNA.
The peptide fractions had more success with the swabs, and this makes sense because the target
proteins are present in the body fluid and not in the cells and are smaller in size compared to
DNA so they might not get as easily trapped.
The purpose of the repeatability study on different substrates was to see if the method
gave reproducible results. With more donors added to the study, the variability of concentrations
on each substrate may or may not follow more of a pattern since there is also variability between
donors. It would be important to study this with a bigger sample size in order to determine which
substrate would provide consistent results donor to donor. In this study, the polyester T-shirt
showed the highest percentage of variability for all the peptides and the cotton swab showed the
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smallest percentage of variability, especially with SMR3B-1 and SMR3B-2. It should also be
noted that NGAL-1 had the highest variability throughout all three substrates. This is due to the
large variation of concentrations between the two donors. Overall, the polyester t-shirt cutting
showed the highest variability for all peptides.
The mixture study showed that all three body fluids can be detected despite the presence
of one or two other body fluids. In this study, the two-component mixtures between vaginal
secretions and semen showed almost no interference in this study. Only at the largest ratio
(100:1) did SEMG-1 and SEMG-2 drop out. Also, SMR3B-1 and SMR3B-2 were only detected
when saliva was a major component. Neither saliva peptides were detected at the 1:1 mixture and
this could be due to the volume that was pipetted (1 µL). SMR3B-2 was also only detected as a
major component and dropped out when only 1 µL of a 1:10 dilution of saliva was pipetted onto
the polyester t-shirt cutting. Furthermore, this part of the study was completed after the saliva
was centrifuged so this could have affected the results. Browne et al. (2019) studied body fluid
mixtures on cotton swabs but also studied other substrates. It was found that the peptide signals
were detected on all substrates. The polyester t-shirt was chosen as the substrate for the mixtures
in this study since it was relatively successful with the peptides and very successful with DNA.
Also, as stated previously, it mocks women’s underwear that may be collected from a sexual
assault. In Browne et al. (2019), it was found that semen and saliva could be both detected in a
mixture except when saliva was the minor component.
Legg et al. (2017) found that relative abundance for the protein markers varies from
person to person. In that study, they found that SEMG had the highest abundance, then SMR3B,
and then NGAL (n=50). In this study, that same pattern was also found. This proves that the
intensity or abundance of the biomarker will not cause interference. Only the volume of the body
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fluid could cause interference. Furthermore, the level of abundance of the peptide in a specific
body fluid speaks for the robustness of the peptide and this assay.
This assay was also capable of detecting body fluids in older samples. The mock case
samples that were studied contained five-year-old vaginal swabs. Although not much
degradation would be expected because the swabs were held in a -20°C freezer, it was still
necessary to see if the assay could detect peptides in older samples. Danielson et al. (2018)
successfully detected blood and semen protein biomarkers in aged samples. The assay in this
study was successful in identifying vaginal fluid, semen, and saliva in all the vaginal swabs.
Most importantly, NGAL-1 was abundant in all three swabs tested.
The total human and male DNA quantitation was an important comparison measure to
ensure DNA fractions contained male DNA and to determine which samples would have yielded
sufficient DNA for STR typing. Overall, the Y-DNA was detected for all the male samples. The
Y-DNA had a higher concentration for samples with semen in it compared to samples with just
saliva, which is consistent with semen containing a larger amount of DNA than saliva (Lee &
Ladd, 2001). Although, it did depend on the donor because semen Donor 1 had a much higher
concentration than semen Donor 2. In the mixtures, the Y-chromosome was detected even when
the semen and saliva were minor components, but due to the differences in DNA content only
the semen samples had enough DNA and a male to DNA ratio sufficient for STR typing.

Conclusions
This assay successfully identified vaginal fluids, saliva, and semen by using signature peptides.
SEMG-1 and SEMG-2 are robust and abundant in samples with semen. SMR3B-1 & 2 are
abundant but not always detected as the minor component in a mixture. Finally, NGAL-1 was
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robust and abundant, but NGAL-2 was not detected in the vaginal samples. Furthermore, this
assay provides a peptide and DNA fraction in unison, so less amount of the sample is used,
which is practical for forensic cases. The DNA fractions were quantified, and it was determined
that downstream analysis could be successfully completed due to sufficient DNA for more
samples. Overall, this assay is robust and sensitive and can be successfully used to identify body
fluids.

Future Work
Future work for this assay is required to make it more specific for vaginal fluids and to
improve the sensitivity for the saliva peptides. An additional vaginal marker to replace NGAL-2
is needed to provide a confirmatory peptide to NGAL-1 to confidently identify a vaginal fluid.
Another NGAL peptide sequence, like the one Danielson et al. (2018) used, is suggested before
trying a different protein. This can be done by using the scan feature with the mass spectrometer
to discover the peptides under these specific experiment conditions. A high-resolution MS
experiment is needed in order to complete a full scan. Also, an internal standard could be added
so that a more accurate quantification can be achieved. An internal standard is constant in each
sample and would help the analyst resolve problems or strange results. Specifically for this
study, the internal standard could have helped explain any unusual concentrations found with
viscous body fluids. As suggested by Merkley et al. (2019), it would be beneficial to use a search
database when searching the samples for the peptides. This would create less bias, and with a
large multiplex, the search database could assist in identifications that would be hard for an
analyst. Another suggestion for further validation would be to try degraded and older samples to
see if the peptides can still identify body fluids under these circumstances. Finally, it would be
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essential to generate the STR profiles for the samples to see if it is possible to interpret the alleles
for the samples in the extreme mixtures.
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